Abstract
A liquid chromatographic (LC) procedure using alumina as stationary phase in both the pre- and the analytical column, is reported for the determination of WR1065, the active metabolite of the amino- and thiol-containing anticancer drug WR2721. After pre-column derivatization of the thiol group, the analyte is determined by LC with diode laser induced fluorescence detection in the near-infrared. Selective removal of excess label is achieved by means of column switching; it allows the detection of 5 × 10
| Original language | English |
|---|---|
| Pages (from-to) | 255 |
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Volume | 13 |
| DOIs | |
| Publication status | Published - 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 6 Clean Water and Sanitation
Fingerprint
Dive into the research topics of 'Determination of the anti-cancer drug metabolite WR1065 using pre-column derivatization and diode laser-induced fluorescence detection.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver